Strides Pharma Science Limited
Strides Pharma Science Limited has intimated participation in an Analyst/Institutional Investors' Meeting under SEBI Listing Regulations (Regulation 30).
The meeting details are as follows:
- Date & Time: June 1, 2026 from 08:30 hours onwards
- Event Type: US Pharma & Healthcare Tour
- Mode/Type of Meeting: In-person (Group Meeting)
- Location: New York, USA
The company specified that the Q4 FY26 earnings presentation, which was previously intimated and uploaded on stock exchanges and the company website on May 18, 2026, will serve as the discussion document during this meeting.
The disclosure acknowledges a delay in intimating the meeting schedule to the stock exchanges, attributing it to the late finalization of the event details.